Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastasesRupert Bartsch, G. Steger, Catharina DeVries et al.|British Journal of Cancer|2011Cited by 77
Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancerRupert Bartsch, Guenther G. Steger, Zsuzsanna Bagó-Horváth et al.|European Journal of Cancer|2012Cited by 52
P4-17-05: Brain Metastasis Free Survival (BMFS) Differs between Breast Cancer Subtypes.Rupert Bartsch, G.G. Steger, Anna S. Berghoff et al.|Cancer Research|2011Cited by 1